ArticleCureus2025
Impact of Health Interventions on Patient Compliance and Clinical Outcomes in Individuals With Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. Objective To assess the effect of a personalized health intervention on treatment compliance and clinical outcomes in patients with diabetes mellitus (DM). Methodology This quasi-experimental study was conducted at the Aga Khan University Hospital, Karachi, from January 2023 to December 2023. Data were collected from 250 DM patients who had constant and direct access to telecommunication devices. Participants were randomly assigned to two groups: Group A, the intervention group, and Group B, the control group. Patient compliance was assessed using a medication adherence questionnaire, which included questions about physical activity and medical appointments. Results Data were collected from 250 diabetic patients in two groups. The mean age in the intervention group was 55.01 ± 9.81 years and in the control group 57.23 ± 9.25 years. There were 125 participants in each group, and among these, in the intervention group, 48% were male and 52% were female. In the intervention group, HbA1c levels decreased from 8.5 ± 1.2% at baseline to 7.2 ± 1.0% at follow-up, compared to marginal changes in the control group (8.7 ± 1.1% to 8.4 ± 1.0%). In the intervention group, mean scores for physical functioning increased from 65 ± 5 at baseline to 75 ± 6 at follow-up, indicating enhanced functional capacity. Similarly, mental health scores showed improvement, with mean values rising from 70 ± 7 to 75 ± 8. Emotional well-being also demonstrated significant enhancement, with mean scores increasing from 60 ± 6 to 70 ± 7. Conclusion It is concluded that the health intervention implemented in this study significantly improved patient compliance and positively impacted health outcomes in diabetes management. With higher adherence rates to prescribed treatments and substantial improvements in key health metrics, including HbA1c levels, blood pressure, and cholesterol, the intervention demonstrated its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.